60 Degrees Pharmaceuticals
SXTP
6 hedge funds and large institutions have $54.8K invested in 60 Degrees Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 4 closing their positions.
0.18% more ownership
Funds ownership: 0.33% → 0.51% (+0.18%)
33% less funds holding
Funds holding: 9 → 6 (-3)
72% less capital invested
Capital invested by funds: $198K → $54.8K (-$143K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$37.2K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$36.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.47K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$128K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$19.9K |
| 3 |
HF
HRT Financial
New York
|
-$16K |
| 4 |
BWL
Bogart Wealth LLC
Mclean,
Virginia
|
-$903 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $29.8K | +$37.2K | +3,027 | +297% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $21.5K | +$36.7K | +2,981 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2.85K | +$2.47K | +201 | +107% |
|
|
SHF
4
Safe Harbor Fiduciary
Pensacola,
Florida
| $506 | – | – | – |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $184 | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $22 | +$25 | +2 | +200% |
|
|
AC
7
Armistice Capital
New York
| – | -$128K | -4,947 | Closed |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$19.9K | -772 | Closed |
|
|
HF
9
HRT Financial
New York
| – | -$16K | -630 | Closed |
|
|
BWL
10
Bogart Wealth LLC
Mclean,
Virginia
| – | -$903 | -35 | Closed |
|
SXTP Hedge Fund Activity: Q1 2025 in Review
6 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q1 2025, worth a combined $54.8K — down 72% from $198K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SXTP and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was UBS Group, adding an estimated $37.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $128K sold.
- 6 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q1 2025, down from 9 in Q4 2024.
- Funds reported $54.8K of 60 Degrees Pharmaceuticals stock for Q1 2025, down 72% quarter-over-quarter.
- 1 fund opened new 60 Degrees Pharmaceuticals positions in Q1 2025 and 4 closed out, a net change of -3 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q1 2025 was UBS Group, an estimated $37.2K added.
- The largest 60 Degrees Pharmaceuticals seller in Q1 2025 was Armistice Capital, an estimated $128K sold.
Based on aggregated 13F filings for Q1 2025.